CRISPR Gene-Editing Stocks Going Down the Tubes? Think Again – Madison.com
Madison.com |
CRISPR Gene-Editing Stocks Going Down the Tubes? Think Again
Madison.com The biotech world was abuzz a little over a week ago with news that the human immune system has built-in defense systems against the Cas9 enzyme used in the CRISPR-Cas9 approach to gene editing. The CRISPR-Cas9 method has revolutionized gene editing … |
